Gabelli & Co Investment Advisers’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-29,650	Closed	-$9.38M	–	284
2023 Q4	$9.38M	Buy	+29,650	New	+$5.76M	1.76%	16

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Gabelli & Co Investment Advisers's KRTX Position: Q1 2024 in Review

Gabelli & Co Investment Advisers sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 29,650 shares — an estimated $9.38M sold.

Gabelli & Co Investment Advisers first reported a position in KRTX in Q4 2023 and held it in 1 quarter. The position peaked at $9.38M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

Gabelli & Co Investment Advisers reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 29,650 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $9.38M.
Gabelli & Co Investment Advisers first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Gabelli & Co Investment Advisers's Karuna Therapeutics, Inc. Common Stock position peaked at $9.38M in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2024, filed 14 May 2024.